Genovis AB (publ.) (GENO.ST)

SEK 24.35

(2.31%)

Long Term Debt Summary of Genovis AB (publ.)

  • Genovis AB (publ.)'s latest annual long term debt in 2023 was 74.8 Million SEK , up 1585.54% from previous year.
  • Genovis AB (publ.)'s latest quarterly long term debt in 2024 Q2 was - SEK , down 0.0% from previous quarter.
  • Genovis AB (publ.) reported annual long term debt of 4.43 Million SEK in 2022, up 295.06% from previous year.
  • Genovis AB (publ.) reported annual long term debt of 1.12 Million SEK in 2021, down -66.14% from previous year.
  • Genovis AB (publ.) reported quarterly long term debt of 75.08 Million SEK for 2024 Q1, down 0.0% from previous quarter.
  • Genovis AB (publ.) reported quarterly long term debt of 4.54 Million SEK for 2023 Q2, up 4.15% from previous quarter.

Annual Long Term Debt Chart of Genovis AB (publ.) (2023 - 2008)

Historical Annual Long Term Debt of Genovis AB (publ.) (2023 - 2008)

Year Long Term Debt Long Term Debt Growth
2023 74.8 Million SEK 1585.54%
2022 4.43 Million SEK 295.06%
2021 1.12 Million SEK -66.14%
2020 3.31 Million SEK 55.49%
2019 2.13 Million SEK -27.44%
2018 2.94 Million SEK 67.51%
2017 1.75 Million SEK 0.0%
2016 - SEK -100.0%
2015 134.77 Thousand SEK -25.24%
2014 180.28 Thousand SEK 0.0%
2013 - SEK 0.0%
2012 - SEK -100.0%
2011 64.54 Thousand SEK -78.81%
2010 304.54 Thousand SEK 0.0%
2009 - SEK 0.0%
2008 - SEK 0.0%

Peer Long Term Debt Comparison of Genovis AB (publ.)

Name Long Term Debt Long Term Debt Difference
Active Biotech AB (publ) 3 Million SEK -2393.6%
Biovica International AB (publ) 4.29 Million SEK -1641.341%
Cantargia AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Cyxone AB (publ) 74 Thousand SEK -100991.892%
Diagonal Bio AB (publ) - SEK -Infinity%
Elicera Therapeutics AB (publ) - SEK -Infinity%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK -5109.471%
Fluicell AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK -8700.941%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Intervacc AB (publ) 142 Thousand SEK -52581.69%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK -129.599%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Sprint Bioscience AB (publ) - SEK -Infinity%
Xbrane Biopharma AB (publ) 112.89 Million SEK 33.738%
Lipum AB (publ) 1.76 Million SEK -4148.041%
Alligator Bioscience AB (publ) 7.51 Million SEK -895.317%
Ziccum AB (publ) 286 Thousand SEK -26056.643%
BioArctic AB (publ) 2.15 Million SEK -3376.208%
Camurus AB (publ) 13.61 Million SEK -449.534%
IRLAB Therapeutics AB (publ) 24.51 Million SEK -205.202%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK -134.163%
Kancera AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK -14.669%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -17543.396%
Karolinska Development AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -7380.8%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 92.038%
Hansa Biopharma AB (publ) 844.9 Million SEK 91.146%
Biosergen AB - SEK -Infinity%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Corline Biomedical AB - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -54905.882%
LIDDS AB (publ) - SEK -Infinity%
Egetis Therapeutics AB (publ) 103.4 Million SEK 27.652%
BioInvent International AB (publ) 14.53 Million SEK -414.675%
SynAct Pharma AB 58 Thousand SEK -128879.31%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -8700.941%
Alzinova AB (publ) 800 Thousand SEK -9251.0%
Ascelia Pharma AB (publ) 176 Thousand SEK -42404.545%
Oncopeptides AB (publ) 106.48 Million SEK 29.749%
Pila Pharma AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 17.558%
Diamyd Medical AB (publ) 30.67 Million SEK -143.897%